Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-12-16: Form 6-K; Period of report 2021-12-15; Description 6-K; Document d233001d6k.htm.
- 2021-12-15: Form 6-K; Period of report 2021-12-14; Description 6-K; Document d255305d6k.htm.
- 2021-12-13: Form 6-K; Period of report 2021-12-13; Description 6-K; Document d232844d6k.htm.
- 2021-11-18: Form 6-K; Period of report 2021-11-18; Description 6-K; Document d605993d6k.htm.